Versiti Acquires Indiana-based Quantigen
Versiti, a national leader in blood health innovation, today announced the acquisition of Quantigen, a specialty lab based in Fishers, Indiana. Further expanding Versiti’s clinical trial expertise and service offering, Quantigen provides a range of services supporting preclinical and clinical research as well as clinical diagnostics.
World-renowned experts at Versiti, Cenetron and Salus IRB provide comprehensive, customized clinical trial services.
Our services extend beyond testing to include protocol review, preclinical research, IRB approval, test selection and interpretation of results, as needed. We offer expert medical and scientific consultation and custom assay development and validation as we strive to fully understand your specific needs, ensuring an exemplary, precise and timely trial structure.
Expertise across the spectrum of blood health
Versiti Clinical Trials has assisted pharmaceutical and medical device companies with regulatory studies, laboratory testing, assay development, and a variety of other research needs in myriad diagnostic areas.
Our highly specialized focus in laboratory medicine and blood health provides an ideal foundation for a range of organizations, including contract research organizations (CROs); central laboratories; pharmaceutical companies; multinational organizations; and IVD, biotechnology and medical device companies.
"Now Available: Flow Cytometry for identification of biomarkers and characterization of immune responses in clinical trials"
Explore our broad range of specialized services
Cenetron Central Laboratory Services
Salus IRB provides institutional review board services for single-site, multi-site and international clinical trials. Salus is a leader in the research review space.
Expert guidance. Every phase. Every day.
At Versiti Clinical Trials, world-renowned experts work together as one to provide complete support for your clinical trials, from start to finish.